Pharmacodynamic biomarkers are essential for several reasons. Firstly, they aid in the drug development process by providing early indications of a drug's efficacy and safety, which can significantly reduce the time and cost involved in bringing a new drug to market. Secondly, they help in individualizing treatment by identifying which patients are more likely to benefit from a particular therapy, thereby optimizing therapeutic outcomes and minimizing adverse effects.